Abstract

Gene editing is known to be powerful, yet controversial. While it has the ability to significantly decrease human immunodeficiency virus (HIV) cases around the world, gene editing can also create an even greater socioeconomic gap. This academic discussion about gene editing has to address when gene editing treatments should be used as well as which type of gene editing treatments should be used. Currently there are two types of gene editing treatments, somatic and germline. Somatic gene editing treatments make modifications to DNA but do not affect reproductive cells. In contrast, germline gene editing practices do affect reproductive cells and modifications can be passed to future generations. The study aims to address San Francisco Bay Area Generation Z’s opinions on gene editing (including which gene editing practices should be used). 
 To test the hypothesis that Generation Z will want gene editing treatments that are meant to treat diseases and other disorders, the researcher utilized a mixed methodology with an online survey. The results showed that somatic gene editing treatments for diseases and disorders in adults are the most prefered use of these technologies. By these means, legislation as well as other research should be done to promote access to treatments, such as those for sickle cell anemia, for the general public.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call